Mitchell Hull
Impact in
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Ubiquitin and proteasome pathways 4
- Protein Degradation and Inhibitors 4
- RNA Research and Splicing 2
- Peroxisome Proliferator-Activated Receptors 2
- Co-authors
- Makoto Makishima (1 shared paper)Joyce J. Repa (1 shared paper)David J. Mangelsdorf (1 shared paper)Hua Tu (1 shared paper)Kevin D. Lustig (1 shared paper)R. Marc Learned (1 shared paper)Alvin Luk (1 shared paper)Bei Shan (1 shared paper)
- Journals
- ACS Chemical Biology (4 papers)SLAS DISCOVERY (2 papers)Journal of the American Chemical Society (2 papers)Proceedings of the National Academy of Sciences (2 papers)eLife (2 papers)
- Partner nations
- United StatesFranceVietnam
In The Last Decade
Mitchell Hull
25 papers receiving 3.2k citations
Mitchell Hull's Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 1.6k
- Pharmacology 268
- Hepatology 200
- Surgery 965
- Epidemiology 564
Countries citing papers authored by Mitchell Hull
This map shows the geographic impact of Mitchell Hull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Hull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Hull more than expected).
Fields of papers citing papers by Mitchell Hull
This network shows the impact of papers produced by Mitchell Hull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Hull. The network helps show where Mitchell Hull may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell Hull, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification of a Nuclear Receptor for Bile Acids Hit paper breakdown → | 1999 | 2304 |
| 2 | 2001 | 232 | |
| 3 | Sulfur(VI) Fluoride Exchange (SuFEx)-Enabled High-Throughput Medicinal Chemistry Hit paper breakdown → | 2020 | 165 |
| 4 | 2018 | 139 | |
| 5 | 2021 | 65 | |
| 6 | 2017 | 57 | |
| 7 | 2020 | 48 | |
| 8 | 2021 | 47 | |
| 9 | 2020 | 38 | |
| 10 | 2017 | 36 | |
| 11 | 2014 | 34 | |
| 12 | 2019 | 28 | |
| 13 | 2020 | 28 | |
| 14 | 2006 | 17 | |
| 15 | 2023 | 14 | |
| 16 | 2021 | 13 | |
| 17 | 2020 | 13 | |
| 18 | 2017 | 12 | |
| 19 | 2020 | 11 | |
| 20 | 2019 | 10 |
About Mitchell Hull
Mitchell Hull is a scholar working on Molecular Biology, Infectious Diseases, Cell Biology, Oncology and Organic Chemistry, having authored 26 papers that have together received 3.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Hippo pathway signaling and YAP/TAZ (4 papers), Protein Degradation and Inhibitors (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), RNA Research and Splicing (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Peptidase Inhibition and Analysis (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Oncology (1.6k citations), Pharmacology (268 citations), Hepatology (200 citations), Surgery (965 citations) and Epidemiology (564 citations). Mitchell Hull has collaborated with scholars based in United States, France and Vietnam. Frequent co-authors include Makoto Makishima, Joyce J. Repa, David J. Mangelsdorf, Hua Tu, Kevin D. Lustig, R. Marc Learned, Alvin Luk, Bei Shan, Jürgen M. Lehmann and Peter Coward. Their work appears in journals such as ACS Chemical Biology, SLAS DISCOVERY, Journal of the American Chemical Society, Proceedings of the National Academy of Sciences and eLife.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.